Valion Bio VBIO
NASDAQ VBIO
$0.12 +0.00 (+0.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Property, Plant & Equipment (Net) (2021 - 2026)

Valion Bio (VBIO) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Valion Bio 405,599.63 -1.79 Mn -45,000.00 12.34 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 12.34 Mn
Jun 30, 2026 12.34 Mn
Dec 31, 2025 12.64 Mn
Dec 31, 2025 12.64 Mn
Sep 30, 2025 12,000.00
Sep 30, 2025 12,000.00
Jun 30, 2025 120,000.00
Jun 30, 2025 120,000.00
Mar 31, 2025 118,000.00
Mar 31, 2025 118,000.00
Dec 31, 2024 2,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 119,000.00
Sep 30, 2024 119,000.00
Jun 30, 2024 120,000.00
Jun 30, 2024 120,000.00
Mar 31, 2024 121,000.00
Mar 31, 2024 121,000.00
Dec 31, 2023 122,000.00
Dec 31, 2023 122,000.00